Name: Smoking and Hormone-Related Disorders (en Inglés)
SKU: 67464478
Price: 170.82 USD
Availability: InStock
Author: John Baron;Nicholas Wald

portada Smoking and Hormone-Related Disorders (en Inglés)

Smoking and Hormone-Related Disorders (en Inglés)

Formato

Libro Físico

Editorial

Oxford University Press

Autor

John Baron;Nicholas Wald

Año

1990

Idioma

Inglés

N° páginas

304

Encuadernación

Tapa Dura

Dimensiones

24.4x16.4x2.3 cm

ISBN13

9780192619358

Smoking and Hormone-Related Disorders (en Inglés)

John Baron;Nicholas Wald (Autor) · Oxford University Press · Tapa Dura

Libro Nuevo Importado

Envío: 18 a 25 días háb.

$ 341.64$ 170.82

-50%

Costos de importación incluídos en el precio ✅

Libro Nuevo

Quedan 10 unidades

$ 170.82

Llega entre el 17 Sep y el 30 Sep a Quito, Pichincha. Seleccionar ubicación

Agregar a lista de deseos

Reseña del libro "Smoking and Hormone-Related Disorders (en Inglés)"

The subject of smoking and the hormone disorders associated with it are of relatively recent interest. Its importance increases as the average age at death of the population increases and many of those people will have had a lifetime smoking. The book provides summaries of the present status of research into the effects of smoking and the apparent protection offered against certain diseases.

The subject of smoking and the hormone disorders associated with it are of relatively recent interest. Its importance increases as the average age at death of the population increases and many of those people will have had a lifetime smoking. The book provides summaries of the present status of research into the effects of smoking and the apparent protection offered against certain diseases. Some research workers have suggested ways of predicting trends of disease patterns such as osteoporetic fractures. Not all the disorders discussed are adverse effects of smoking and these have provided impetus for developing non-tobacco methods of disease prevention. As the smoking population diminishes and the availability of lower tar brands increases, a reduction in many of the adverse disorders is expected and will form the basis for continued monitoring.